2020 highlights

22

Ethical commitments

included in our new Code of Ethics, co-created with more than 3 000 Novartis associates

98%

Associates

completed global e-training on the new Code of Ethics (rollout to be completed by February 2021)

8 400+

Suppliers

risk-assessed through our Third-Party Risk Management program, with 120 engagements stopped due to assessment outcomes

66 m

Patients

reached with products through our access activities

369 000

Patients

reached with our emerging market brands in 2020

8 m

People

reached with health education at awareness events

980 m

Treatment courses

of Coartem delivered in the past two decades in malaria-endemic countries

3 400+

Patients

treated for sickle cell disease with hydroxyurea in 11 treatment centers in Ghana

7.3 m

Patients

reached with free multidrug therapy for leprosy since 2000

19%

Reduction

in greenhouse gas emissions vs. 2016 baseline

45%

Women

in management

60 000

Hours

of learning on topics such as innovation, digital skills, and access to medicines during Curiosity Month in September